Sinovac CEO Yin Weidong announced in an interview with Bloomberg that they have given production licenses to five countries, including Turkey.
In the news of Bloomberg HT, Sinovac stated that while defending different clinical results, there is evidence showing that CoronaVac gives better results in the real world.
Sinovac CEO Yin Weidong stated that together with Turkey, they gave a license to Indonesia, Brazil, Malaysia and Egypt to produce the vaccine in their countries.
6 MILLION DOSE PRODUCTION IS MADE A DAY
Yin Weidong, CEO of Sinovac Biotech, said in a statement last month at the annual Boao Forum for Asia that the company produces more than 6 million doses of vaccine per day.
Adding that joint production abroad was insufficient, Yin used the expressions, “We plan to select 10 countries to transfer technology as soon as possible.”
Recent clinical trials of the Sinovac vaccine took place in Chile.
It was stated that the corona virus vaccine Coronavac of the Chinese company Sinovac was 85 percent effective in preventing hospitalizations and 80 percent effective in preventing deaths, while the vaccine was reported to be 67% effective in preventing symptomatic cases.
The Chilean government shared the first real efficacy research results of the Chinese vaccine. The study revealed how effective the vaccine was outside of clinical trials.
The study examined its effectiveness on 10.5 million people with the CoronaVac vaccine between February 2 and April 1.